Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
Guigay, J., Fayette, J., Dillies, A. F., Sire, C., Kerger, J. N., Tennevet, I., Machiels, J. P., Zanetta, S., Pointreau, Y., Bozec Le Moal, L., Henry, S., Schilf, A., Bourhis, J.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv268
Date:
June, 2015
File:
PDF, 1.01 MB
english, 2015
File converter
More search results
More benefits 
